We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.93B
AUM Growth
+$141M
Cap. Flow
+$21.7M
Cap. Flow %
1.12%
Top 10 Hldgs %
33.07%
Holding
637
New
137
Increased
190
Reduced
159
Closed
87

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 7.39%
3 Consumer Discretionary 5.07%
4 Financials 4.88%
5 Communication Services 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVW icon
101
iShares S&P 500 Growth ETF
IVW
$73B
$3.58M 0.19%
61,940
-4,896
-7% -$277K
TSM icon
102
TSMC
TSM
$2.11T
$3.58M 0.19%
44,100
+20,051
+83% +$1.52M
AMGN icon
103
Amgen
AMGN
$203B
$3.57M 0.18%
14,032
+488
+4% +$121K
IVE icon
104
iShares S&P 500 Value ETF
IVE
$49B
$3.51M 0.18%
31,236
-819
-3% -$92.8K
NSIT icon
105
Insight Enterprises
NSIT
$3.61B
$3.5M 0.18%
61,809
+20,149
+48% +$1.08M
SGMO
106
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.5M 0.18%
370,100
-34,900
-9% -$377K
ATVI
107
DELISTED
Activision Blizzard
ATVI
$3.48M 0.18%
43,035
+777
+2% +$63K
IWN icon
108
iShares Russell 2000 Value ETF
IWN
$14.5B
$3.39M 0.18%
34,097
-244
-0.7% -$24.8K
ITCI
109
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.39M 0.18%
132,000
-9,000
-6% -$205K
VOO icon
110
Vanguard S&P 500 ETF
VOO
$973B
$3.38M 0.17%
10,969
+1,313
+14% +$400K
GNMA icon
111
iShares GNMA Bond ETF
GNMA
$422M
$3.35M 0.17%
65,605
+6,942
+12% +$355K
MRSN
112
DELISTED
Mersana Therapeutics
MRSN
$3.22M 0.17%
6,920
-720
-9% -$364K
AUPH icon
113
Aurinia Pharmaceuticals
AUPH
$1.96B
$3.11M 0.16%
211,000
+161,000
+322% +$2.33M
KLAC icon
114
KLA
KLAC
$280B
$3.06M 0.16%
158,100
B
115
Barrick Mining
B
$63B
$3.03M 0.16%
+107,804
New +$3.07M
TEL icon
116
TE Connectivity
TEL
$58.5B
$3.02M 0.16%
30,916
+4,000
+15% +$368K
EA icon
117
Electronic Arts
EA
$52.4B
$3.02M 0.16%
23,144
-2,400
-9% -$327K
XLRE icon
118
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
$3.02M 0.16%
85,595
-3,743
-4% -$133K
BABA icon
119
Alibaba
BABA
$271B
$3.01M 0.16%
10,243
+539
+6% +$142K
IGSB icon
120
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$2.99M 0.15%
54,441
+15,112
+38% +$830K
SCHX icon
121
Schwab US Large- Cap ETF
SCHX
$71.2B
$2.99M 0.15%
222,456
-1,218
-0.5% -$16.2K
IGF icon
122
iShares Global Infrastructure ETF
IGF
$11B
$2.99M 0.15%
77,454
EEFT icon
123
Euronet Worldwide
EEFT
$2.97B
$2.98M 0.15%
32,725
HUM icon
124
Humana
HUM
$47.3B
$2.94M 0.15%
7,093
-71
-1% -$28.6K
ESML icon
125
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.85B
$2.93M 0.15%
110,563
+3,894
+4% +$103K

Similar funds

Bailard's Q3 2020 Portfolio in Review

As of Q3 2020, Bailard held 637 positions worth $1.93B, up 7.9% from $1.79B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bailard's Q3 2020 filing shows 137 new, 190 increased, 159 reduced and 87 closed positions. Its largest new stake was Vanguard Mortgage-Backed Securities ETF: 420,231 shares worth $22.8M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $62.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Bailard's largest Q3 2020 buy was Vanguard Mortgage-Backed Securities ETF: 420,231 shares worth $22.8M.
  • Bailard added most to iShares MSCI Emerging Markets ETF in Q3 2020, an estimated $59.1M increase.
  • Bailard's biggest Q3 2020 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $62.7M.
  • Bailard fully exited Teva Pharmaceuticals in Q3 2020, selling an estimated $4.09M.
  • Bailard's ten largest holdings make up 33% of its $1.93B portfolio in Q3 2020.
  • Bailard opened 137 new positions and closed 87 in Q3 2020.
  • Bailard's portfolio value rose 7.9% quarter-over-quarter to $1.93B.

Based on Bailard's 13F filing for Q3 2020, filed 10 Nov 2020.